InsidersTradesSigma
Fortress Biotech, Inc. Stock: price and management transactions · United States · SEC (Form 4)
Follow the Fortress Biotech, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Fortress Biotech, Inc. has published 71 public disclosures. Market capitalisation: €101m. The latest transaction was reported on 24 June 2026 (Attribution). Among the most active insiders: ROSENWALD LINDSAY A MD. Every trade is accessible without an account.
71
Insider Decl.
0
Thresholds
€8m
22 ops.
Buy Volume
€92,941
2 ops.
Sell Volume
42Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 17,440 of 25,791 companies
40.4
score / 100
Value13
Quality68
FCF yld-66%
Earn yld-1.9%
EV/EBITDA·
ROE110%
Gross mgn67%
Net mgn-3.0%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 24 June 2026
Declarations71 total
49,383 shares0Common Stock, par value $0.001SEC:0001415889-25-000425:0
49,383 shares0common stock, par value $0.001SEC:0001415889-25-000444:0
454,153 shares0common stock, par value $0.001SEC:0001415889-25-000402:0
49,383 shares0common stock, par value $0.001SEC:0001415889-25-000427:0
454,153 shares0Common stock, par value $0.001SEC:0001415889-25-000400:0
49,383 shares0common stock, par value $0.001SEC:0001415889-25-000426:0
763,359 shares@ US$1.8420.5% of flowCommon stock, par value $0.001SEC:0001415889-24-023957:0
Ideal exit: 20 Jun 2025 (T+270)
5,000 shares@ US$7.48350.6% of flowSERIES A CUMULATIVE PERPETUAL PREFERRED STOCKSEC:0001104659-24-079855:0
Ideal exit: 7 Apr 2025 (T+270)
5,000 shares@ US$7.39420.6% of flowSERIES A CUMULATIVE PERPETUAL PREFERRED STOCKSEC:0001104659-24-079100:0
Ideal exit: 5 Apr 2025 (T+270)
5,000 shares@ US$7.35290.6% of flowSERIES A CUMULATIVE PERPETUAL PREFERRED STOCKSEC:0001104659-24-078786:0
Ideal exit: 4 Apr 2025 (T+270)
20,000 shares@ US$1.63620.5% of flowCOMMON STOCK, PAR VALUE $0.001SEC:0001104659-24-076591:0
Ideal exit: 25 Mar 2025 (T+270)
10,000 shares@ US$1.75890.3% of flowCOMMON STOCK, PAR VALUE $0.001SEC:0001104659-24-063455:0
Ideal exit: 10 Feb 2025 (T+270)
50,000 shares@ US$2.37541.8% of flowCOMMON STOCK, PAR VALUE $0.001SEC:0001104659-24-002464:0
Ideal exit: 1 Oct 2024 (T+270)
3,333 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-24-000905:0
3,333 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-24-000913:0
6,666 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-24-000899:0
25 of 71 declarations
About Fortress Biotech, Inc.
Fortress Biotech, Inc. is a company focused on developing innovative therapies for the treatment of diseases. It primarily operates in the healthcare and pharmaceutical sector, listed on NASDAQ.